115 related articles for article (PubMed ID: 1389100)
41. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma.
Leonardi R; Pannone G; Magro G; Kudo Y; Takata T; Lo Muzio L
Oncol Rep; 2002; 9(2):261-6. PubMed ID: 11836590
[TBL] [Abstract][Full Text] [Related]
43. Production of fibronectin by human epithelial cells in culture.
Smith HS; Riggs JL; Mosesson MW
Cancer Res; 1979 Oct; 39(10):4138-44. PubMed ID: 383280
[TBL] [Abstract][Full Text] [Related]
44. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.
Mandel U; Hassan H; Therkildsen MH; Rygaard J; Jakobsen MH; Juhl BR; Dabelsteen E; Clausen H
Glycobiology; 1999 Jan; 9(1):43-52. PubMed ID: 9884405
[TBL] [Abstract][Full Text] [Related]
45. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L
Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891
[TBL] [Abstract][Full Text] [Related]
46. Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid.
Frank HG; Huppertz B; Kertschanska S; Blanchard D; Roelcke D; Kaufmann P
Histochem Cell Biol; 1995 Oct; 104(4):317-29. PubMed ID: 8548566
[TBL] [Abstract][Full Text] [Related]
47. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
48. [An expression of tumor-associated antigen which was recognized by a monoclonal antibody KM-93 in oral tumor--comparison between tissue antigen and serum antigen].
Tsuji T; Matsumura K; Suzuki M; Nakashima K; Shinozaki F; Sasaki K; Takahashi M; Ogino T
Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1645-50. PubMed ID: 3193013
[No Abstract] [Full Text] [Related]
49. Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid-phase synthesis and antigenic activity.
Zheng M; Gobbo M; Biondi L; Filira F; Hakomori S; Rocchi R
Int J Pept Protein Res; 1994 Mar; 43(3):230-8. PubMed ID: 8005745
[TBL] [Abstract][Full Text] [Related]
50. Common senescent cell-specific antibody epitopes on fibronectin in species and cells of varied origin.
Porter MB; Pereira-Smith OM; Smith JR
J Cell Physiol; 1992 Mar; 150(3):545-51. PubMed ID: 1371514
[TBL] [Abstract][Full Text] [Related]
51. Solution synthesis of the glyco-hexapeptide sequence of the human oncofetal fibronectin defined by monoclonal antibody FDC-6.
Gobbo M; Biondi L; Filira F; Rocchi R
Int J Pept Protein Res; 1991 Nov; 38(5):417-27. PubMed ID: 1724973
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
[TBL] [Abstract][Full Text] [Related]
53. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.
Kosmehl H; Berndt A; Katenkamp D
Virchows Arch; 1996 Dec; 429(6):311-22. PubMed ID: 8982375
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibody against human fibronectin which inhibits cell attachment.
Schoen RC; Bentley KL; Klebe RJ
Hybridoma; 1982; 1(2):99-108. PubMed ID: 6208125
[TBL] [Abstract][Full Text] [Related]
55. Expression of oncofetal fibronectin in porcine conceptuses and uterus throughout gestation.
Tuo W; Bazer FW
Reprod Fertil Dev; 1996; 8(8):1207-13. PubMed ID: 8981646
[TBL] [Abstract][Full Text] [Related]
56. A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors.
Mariani G; Lasku A; Pau A; Villa G; Motta C; Calcagno G; Taddei GZ; Castellani P; Syrigos K; Dorcaratto A; Epenetos AA; Zardi L; Viale GA
Cancer; 1997 Dec; 80(12 Suppl):2484-9. PubMed ID: 9406699
[TBL] [Abstract][Full Text] [Related]
57. A rapid and highly sensitive solid-phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody.
Salonen EM; Vartio T; Miggiano V; Stähli C; Tacács B; Virgallita G; De Petro G; Barlati S; Vaheri A
J Immunol Methods; 1984 Aug; 72(1):145-56. PubMed ID: 6205094
[TBL] [Abstract][Full Text] [Related]
58. Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin.
Ding Y; Gelfenbeyn K; Freire-de-Lima L; Handa K; Hakomori SI
FEBS Lett; 2012 Jun; 586(13):1813-20. PubMed ID: 22641031
[TBL] [Abstract][Full Text] [Related]
59. A difference between plasma and cellular fibronectins located with monoclonal antibodies.
Atherton BT; Hynes RO
Cell; 1981 Jul; 25(1):133-41. PubMed ID: 6168385
[TBL] [Abstract][Full Text] [Related]
60. Production of fibronectin by human tumor cells and interaction with exogenous fibronectin: comparison of cell lines obtained from colon adenocarcinomas and squamous carcinomas of the upper aerodigestive tract.
Varani J; Schuger L; Fligiel SE; Inman DR; Chakrabarty S
Int J Cancer; 1991 Feb; 47(3):421-5. PubMed ID: 1993550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
